Immunoglobulin light chain amyloidosis: 2022 update on diagnosis, prognosis, and treatment

Medicine & Life Sciences

• Immunoglobulin Light-chain Amyloidosis 100%
• Immunoglobulin Light Chains 61%
• Amyloid 42%
• pro-brain natriuretic peptide (1-76) 39%
• daratumumab 25%
• pomalidomide 24%
• Smoldering Multiple Myeloma 23%
• venetoclax 23%
• Bendamustine Hydrochloride 22%
• Birefringence 21%
• Monoclonal Gammopathy of Undetermined Significance 21%
• Congo Red 19%
• Immunoglobulin Heavy Chains 19%
• Natriuretic Peptides 18%
• Bortezomib 18%
• Troponin T 18%
• Biopsy 18%
• Troponin I 17%
• Nephrotic Syndrome 16%
• Delayed Diagnosis 16%
• Amyloid Plaques 16%
• Peripheral Nervous System Diseases 15%
• Stem Cell Transplantation 15%
• Plasma Cells 14%
• Cyclophosphamide 13%
• Dexamethasone 13%
• Mass Spectrometry 13%
• Therapeutics 12%
• Lasers 11%
• Heart Failure 10%
• Survival 8%
• Antibodies 8%
• Liver 7%
• Serum 6%